Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003727825 | SCV004535412 | uncertain significance | not provided | 2023-09-03 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects CSF1R function (PMID: 30982609). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CSF1R protein function. ClinVar contains an entry for this variant (Variation ID: 635119). This missense change has been observed in individual(s) with autosomal recessive CSF1R-related conditions (PMID: 30982609). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 132 of the CSF1R protein (p.Pro132Leu). |
OMIM | RCV000785984 | SCV000924614 | pathogenic | Brain abnormalities, neurodegeneration, and dysosteosclerosis | 2019-06-21 | no assertion criteria provided | literature only |